A simple neck scan can identify men with double the risk of heart failure, according to research led by University College ...
Patients visiting US emergency departments for altered mental status commonly receive nonspecific symptom diagnoses, ...
Nearly half of adults with a first myocardial infarction show low or borderline risk on current risk estimators. Most develop ...
Bayer’s asundexian meets primary efficacy and safety endpoints in landmark phase III OCEANIC-STROKE study in secondary stroke prevention: Berlin Tuesday, November 25, 2025, 11:0 ...
Bayer's asundexian hits key goals in the OCEANIC-STROKE study, showing reduced ischemic stroke risk without added major ...
Asundexian (Bayer) significantly reduces the risk of ischemic stroke compared with placebo, without increasing the risk of ...
Emirates News Agency on MSN
Bayer’s Asundexian meets main goals in Phase III stroke trial
Bayer Sunday announced positive topline results from the global Phase III study OCEANIC-STROKE, with its investigational, once daily, oral FXIa inhibitor asundexian.The study met its primary efficacy ...
A research paper by scientists at the Capital Medical University evaluated sex differences in stroke recurrence among ...
Cluster randomized trial in Veterans Affairs hospitals shows a tailored quality intervention multiplies sleep apnea testing ...
A Franklin woman is seeking $5 million from Otsego County, claiming two sheriff’s deputies arrested her while she was in visible medical distress.
Dr Chawla warns that stroke occur suddenly and explains how to recognise the warning signs, also known as Transient Ischemic Attacks.
Results from the international VESALIUS-CV (TIMI 66) clinical trial found that among adults with atherosclerotic cardiovascular disease (ASCVD) or diabetes and no history of a prior heart attack or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results